Hu, X., Shi, X., He, S., Chen, J., Chen, Y., Zhu, Q., Zhao, J., Shi, Y., Tang, Y., Zhang, X., Liang, J., Zhao, J., Liu, J., Chen, N., Shen, P., Yao, J., Sun, G., Liu, Z., Zeng, H. (2026). A prospective, multi-center, phase Ib/II trial of first-line cadonilimab plus axitinib in advanced non–clear cell renal cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4501